Concourse Financial Group Securities, Inc. Novo Cure LTD Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
295Shares Held
75.8MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$195 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$147 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$79.5 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$45.2 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.73B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...